VANCOUVER, British Columbia, December 7, 2011 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Apple (NASDAQ:AAPL), General Electric (NYSE:GE), Pfizer (NYSE:PFE), Lehman Brothers (PINK:LEHMQ), Bristol Myers Squibb (NYSE:BMY) & Toll Brothers (NYSE:TOL).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Report Highlights:
Apple Inc. (NASDAQ:AAPL): Apple Inc. (AAPL) was the most-owned stock of the 50 largest hedge funds in the United States during the third quarter. Apple Inc. and five e-book publishers are being investigated by European Union antitrust regulators over deals that may restrict sales across the region. The probe targets the iPad-maker's deals with Lagardere SCA (MMB)'s Hachette Livre, News Corp. (NWSA)'s Harper Collins, CBS Corp.'s Simon & Schuster, Pearson Plc (PSON)'s Penguin and Verlagsgruppe Georg von Holtzbrinck GmbH's Macmillan division, the European Commission said in an e-mailed statement. Last Thursday, Jeffrey Williams, the company Senior Vice President sold about US$1.16 million stock shares at a price of US$385.72. Want to trace the activities of company insiders from now on? Check out the insider trading here. Read Full Report: http://www.insiderslab.com/PR3/120711A/AAPL/Apple.pdf
General Electric Company (NYSE:GE): General Electric Co. investors (GE) eager to find out when the finance unit will resume sharing some of its free cash with the parent company, one indicator of renewed health and safety, will have to wait until the Federal Reserve finishes an inaugural review. Before the financial crisis of 2008, GE Capital paid about 40 percent of its earnings, or as much as US$8.6 billion one year, to the parent company. GE stock has fallen 37 percent since credit markets froze following the bankruptcy of Lehman Brothers Holdings Inc. in September 2008, raising concerns about risk to the value of GE Capital's holdings. Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to find out how they do it? Read Full Report: http://www.insiderslab.com/PR3/120711A/GE/GeneralElectric.pdf
Pfizer Inc. (NYSE:PFE): Pfizer Inc. recently announced that it has completed its previously announced acquisition of Ferrosan Consumer Health's business, which includes dietary supplements and lifestyle products, from Altor 2003 Fund GP Limited. "Today, we have taken an important step by adding leading brands to our existing portfolio as well as enhancing our presence in established and emerging markets such as the Nordic countries, Russia and Ukraine. Through this acquisition, we'll have the opportunity to provide a broader portfolio of highly trusted and differentiated products to consumers," Paul Sturman said, President, Pfizer Consumer Healthcare. Do you want to know when company insiders will buy their shares? Want to add and monitor this company on an on-going basis? It can be done for free by registering below. Read Full Report: http://www.insiderslab.com/PR3/120711A/PFE/Pfizer.pdf
Today Insiderslab.com released other research reports for:
Lehman Brothers Holdings Inc. (PINK:LEHMQ):
Read Full Report: http://www.insiderslab.com/PR3/120711A/LEHMQ/LehmanBrothers.pdf
Bristol Myers Squibb Co. (NYSE:BMY):
Read Full Report: http://www.insiderslab.com/PR3/120711A/BMY/BristolMyersSquibb.pdf
Toll Brothers, Inc. (NYSE:TOL):
Read Full Report: http://www.insiderslab.com/PR3/120711A/TOL/TollBrothers.pdf
More Individual Stock Reports & Sector Reports:
http://www.insiderslab.com/media/
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Insiderslab.com:
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit http://www.insiderslab.com/disclaimers/disclaimers.php for details.
